TSE:TH Theratechnologies (TH) Stock Price, News & Analysis C$2.50 +0.10 (+4.17%) (As of 12/20/2024 05:18 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades About Theratechnologies Stock (TSE:TH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Theratechnologies alerts:Sign Up Key Stats Today's RangeC$2.28▼C$2.5550-Day RangeC$1.67▼C$2.5652-Week RangeC$1.59▼C$3.43Volume50,062 shsAverage Volume32,685 shsMarket CapitalizationC$114.95 millionP/E RatioN/ADividend Yield3.76%Price TargetN/AConsensus RatingBuy Company OverviewTheratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.Read More… Receive TH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address TH Stock News HeadlinesTheratechnologies Seeks FDA Approval for Manufacturing Changes to EGRIFTA SV®December 20 at 6:25 AM | markets.businessinsider.comTheratechnologies' Initial Efficacy Data From Ovarian Cancer Drug Trial Shows Encouraging ResultsDecember 9, 2024 | markets.businessinsider.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.December 22, 2024 | Stansberry Research (Ad)Theratechnologies expands rare disease portfolio with Ionis partnershipDecember 5, 2024 | msn.comTheratechnologies Secures New $75 Million Credit FacilitiesDecember 3, 2024 | markets.businessinsider.comTheratechnologies Resubmits Tesamorelin Application to FDANovember 26, 2024 | markets.businessinsider.comTheratechnologies resubmits BLA for new tesamorelin formulationNovember 26, 2024 | msn.comTheratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagOctober 12, 2024 | finance.yahoo.comSee More Headlines TH Stock Analysis - Frequently Asked Questions How have TH shares performed this year? Theratechnologies' stock was trading at C$2.14 at the beginning of 2024. Since then, TH shares have increased by 16.8% and is now trading at C$2.50. View the best growth stocks for 2024 here. How were Theratechnologies' earnings last quarter? Theratechnologies Inc. (TSE:TH) posted its quarterly earnings data on Thursday, October, 10th. The company reported $0.09 earnings per share for the quarter. The firm had revenue of $30.96 million for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative trailing twelve-month return on equity of 1,116.86%. How do I buy shares of Theratechnologies? Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Theratechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include Theratechnologies (THTX), Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Vanguard Extended Duration Treasury ETF (EDV) and Nemaska Lithium (NMX). Company Calendar Last Earnings10/10/2024Today12/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryRestaurants, Hotels, Motels Current SymbolTSE:TH CUSIPN/A CIKN/A Webwww.theratech.com Phone+1-514-3367800FaxN/AEmployees103Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.18) Trailing P/E RatioN/A Forward P/E Ratio83.71 P/E Growth-8.5Net IncomeC$-7,000,000.00 Net Margins-8.47% Pretax MarginN/A Return on Equity-1,116.86% Return on Assets5.15% Debt Debt-to-Equity Ratio562.07 Current Ratio1.10 Quick Ratio0.64 Sales & Book Value Annual SalesC$82.57 million Price / Sales1.39 Cash FlowC$0.66 per share Price / Cash Flow3.76 Book ValueC($0.50) per share Price / Book-5.00Miscellaneous Outstanding Shares45,980,000Free FloatN/AMarket CapC$114.95 million OptionableNot Optionable Beta1.73 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (TSE:TH) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.